High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma. (Q52900369)
Jump to navigation
Jump to search
scientific article published in December 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma. |
scientific article published in December 1997 |
Statements
High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma (English)
1 reference
H K Kim
C C Lin
D Parker
J Veals
J Lim
P Likhari
P Statkevich
A Marco
1 December 1997